[BrexitDB NOTE: These agencies have now left the UK.] Wrangle around European Medicines Agency and European Banking Authority after Brussels insists they must leave UK.

As the EU referendum grows ever closer, Lord Darzi, Elias Mossialos and colleagues seek to redress a lack of evidence on the role of the union on our health system.

In the political realm, no one knows how Brexit’s long-running theater of the absurd will end. But for much of the business world, Britain’s departure from the European Union has effectively happened.

Trade unions and regulatory experts warn that budget and staff cuts may lead to drug approval delays or the UK regulator simply rubber-stamping EMA decisions.

Education secretary lauds vaccine rollout saying scientists in UK better than in France, Belgium or US.

NICE has a global reputation as a pioneering HTA – but is that influence at risk now that the UK has left the EU? Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage.

European Medicines Agency heads for Amsterdam 63 days before Brexit.

David Davis claims medicine and banking bodies will not have to leave Canary Wharf.

An organisation which represents medicines wholesalers says supplying Northern Ireland remains "challenging, problematic and inefficient".

There are a number of measures that the UK Government must take in order to address the challenges of leaving the EU's single market.

Preparing Brexit: How ready is the UK? is our second report examining government and business preparations for the end of the transition period, building on Preparing Brexit: The scale of the task left for UK government and business, published in July.

The headlong rush to an end nobody voted for, and why No Deal is a man-made asteroid strike. ... Linguistic programming as Johnson drills the buzzphrase “undemocratic backstop” into the national mind. ... Ingrid – our secret agent within the Tory Party – finally succumbs to Stockholm Syndrome. The Government’s snappy 1,400 page No Deal for small businesses.

A new EU directive is allowing member states to remove the charge for ‘supply and installation of solar panels’.

The hot rhetoric of ‘taking back control’ of our borders is being replaced by cold reality.

"If you will do this damn silly thing, don't do it in this damn silly way. This bill will come back to haunt this gov't, in the same way so many other mistakes, harrumphed to the rafters in this House, have."

The government and its supporters are beginning to claim 'benefits' of being outside the European Union some of which were always available to EU member states or, in other cases, are not benefits at all.

The divorce from the EU looks set to be delayed and could be softened or even abandoned, but the cost of separation is already apparent.

Six years after the referendum we can disentangle the evidence and judge the effects on health and care, says Richard Vize.

This note summarises the evidence so far of the impacts on Brexit on Scotland. It sets out early evidence related to areas such as trade, the workforce and EU programmes.

The negotiations which will set our relationship with our closest neighbours for the next generation are being rushed in a reckless game of chicken.

Britain must work with other countries to prevent friction on medicine rules post-Brexit to avoid being sidelined by the global drug industry, according to a report from the U.K.’s biggest pharmaceutical lobby group.

Fears extra expense and paperwork caused by Brexit will make Britain unattractive to global drugmakers.

As obvious as it is to see the decline in the number of clinical trials in the UK, the reasons behind this trend are as complicated to ascertain. Fiona Maini, Principal - Global Compliance and Strategy at Medidata Solutions, thinks the issue is multifaced with Brexit playing a part in this.